Charles River Laboratories International (CRL) Equity Ratio (2009 - 2025)

Charles River Laboratories International (CRL) has reported Equity Ratio for 17 consecutive years, with 0.44 the latest figure, recorded in Q4 2025.

• In Q4 2025, Equity Ratio fell 3.38% year-over-year to 0.44; the TTM figure through Dec 2025 stood at 0.44 (down 3.38% YoY), while the FY2025 annual figure was 0.44, down 3.38% from the prior year.
• Equity Ratio came in at 0.44 for Q4 2025 at Charles River Laboratories International, down from 0.45 in the prior quarter.
• The five-year high for Equity Ratio was 0.47 in Q3 2024, with the low at 0.34 in Q3 2021.
• Average Equity Ratio over 5 years is 0.41, with a median of 0.42 recorded in 2023.
• Across the five-year window, Equity Ratio decreased 6.3% in 2021 and rose 22.05% in 2023, its largest moves.
• Year by year, Equity Ratio stood at 0.36 in 2021, then rose by 8.48% to 0.39 in 2022, then increased by 12.11% to 0.44 in 2023, then rose by 4.6% to 0.46 in 2024, then declined by 3.38% to 0.44 in 2025.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.44, 0.45, and 0.44 for Q4 2025, Q3 2025, and Q2 2025 respectively.